You are here

Valeo Pharma Inc.

Valeo Pharma Inc.
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
VPH
CSE Index: 
Currency: 

Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory diseases, Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter.

You are here

Valeo Pharma Inc. (VPH)

SEDAR Information

Company Info

Address
16667 Hymus Blvd
Kirkland, QC H9H 4R9
Canada
Phone
514-694-0150
Fax
514-694-0865
Email
mainville@valeopharma.com
Website
http://www.valeopharma.com
Listing date
Wednesday, February 20, 2019
Transfer Agent
Computershare Investor Services Inc.

Capitalization

Issued & Outstanding: 
81649098
Reserved for Issuance: 
41318146

Bulletins

25/03/2022

2022-0334 - Delist - Valeo Pharma Inc. (VPH, VPH.WT, VPH.WT.A)

le 25 mars/March 2022

At the request of the company the common shares and warrants of Valeo Pharma Inc. will be delisted at market close on March 28, 2022.

The securities will continue to trade on the Toronto Stock Exchange.

___________________________

À la demande de la société, les actions ordinaires et les bons de souscription de Valeo Pharma Inc. seront radiés à la clôture du marché le 28 mars 2022.

Les titres continueront d'être négociés à la Bourse de Toronto.